Carol A. Rosenberg, ’80 MD, has more than three decades’ experience as an internist, clinical researcher and medical educator, but it was an unexpected medical crisis within her own family that profoundly changed the course of her career.
A Northwestern Medicine study unearthed the mechanisms behind arsenic’s anti-cancer effects to show how the chemical compound could combat multiple types of leukemia.
Northwestern Medicine scientists have discovered a new potential drug therapy for pediatric brainstem glioma by targeting a genetic mutation found in patients with the rare, incurable cancer.
Leonidas Platanias, MD, PhD, has been appointed director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a position he has served in interim since January.
Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.